NATCO PHARMA: RS 14.86 CRS NSE BLOCK TRADE FOR ~ 250113 SHARES, AT RS 594.15
FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
Find answers to all your questions on live NATCOPHARM message board: Is NATCOPHARM buy or sell? Should I buy NATCOPHARM shares? Why are NATCOPHARM shares falling? Should I invest in NATCOPHARM stock?
forum
NATCOPHARM Share Price Discussion
Natco Pharma Ltd.
NSE: NATCOPHARM | BSE: 524816 | ISIN: INE987B01026 | Sector: Pharmaceuticals and health care
Reputation: 3,033 • Jul 30 2:58 AM
Pfizer’s Upjohn-Mylan merger may have little impact on India operations
As part of the Upjohn-Mylan deal, the Indian unit of US drug major Pfizer announced on July 30 that it will be transferring six brands to the combined entity.
As part of the Upjohn-Mylan deal, the Indian unit of US drug major Pfizer announced on July 30 that it will be transferring six brands to the combined entity.
moneycontrol.com
Like
Reply
Recent posts in NATCOPHARM
Reputation: 3,033 • May 26 2:48 AM
Piramal Enter Consolidated March 2020 Net Sales at Rs 3,341.00 crore, down 9.2% Y-o-Y
Moneycontrol
Like
Reply
Reputation: -10,149 • May 21 7:04 AM
NATCO PHARMA RS 17.97 CRS NSE BLOCK TRADE; FOR~302932 SHARES, AT RS 593.15
Like
Reply
Reputation: -10,149 • May 21 6:24 AM
NATCO PHARMA RS 14.88 CRS NSE BLOCK TRADE; FOR~ 250117 SHARES, AT RS 595
Like
Reply
Reputation: 3,033 • May 19 8:38 AM
Coronavirus pandemic | Natco Pharma donates chloroquine tablets for global trials
The trial will examine whether the anti-malarial drug can protect essential healthcare workers from COVID-19 virus.
The trial will examine whether the anti-malarial drug can protect essential healthcare workers from COVID-19 virus.
Moneycontrol
Like
Reply